Written by bestselling authors Heidi M. Neck, Christopher P. Neck, and Emma L. Murray, Introduction to Business explores the fundamental building blocks of modern business while addressing social impact, ethics, and the power of innovation throughout. Cases on startups, small businesses, and corporations will ignite student interest as they learn from today’s most forward-looking organizations. Regardless of your students’ career aspirations, they will develop the mindset and skillset they need to succeed in their professional journeys.
In the beginning was the word – and the foreword. Words are c- bined to sentences and eventually language. Words are listed in a dictionary and their meaning in building language are explained in a lexicon. In the life sciences – e. g. drug development sciences and pharmaceutical medicine – the analogies are evidenced by the - nomic library and patho-physiological function as the lexicon. In this transition from code to function integrated lexica pay a pivotal role for a faster understanding. The present updated version of this books combines dictionary and lexicon and provides the translational - derstanding of the complex drug development process. With a large number of new terms, their abbreviations and explanations in this complex interdisciplinary process a great number of different dis- plines and specialists need to be informed: they include physicians, pharmacists, biologists, chemists, biostatisticians, data managers, - formation specialists, business developers, marketing experts as well as regulators, financing specialists, healthcare providers and ins- ers in a continuous professional development mode. This lexicon is therefore a most suitable and economical tool for fast and conclusive information for all key-players in the development of medicines at the working place, in postgraduate training as well as during graduate education. This book is an indispensible aid in any medical library. Prof. Dr. med. Dr. h. c. Fritz R.
This book discusses the theoretical and practical aspects required to formulate conventional drug dosage forms and advanced technology-based therapeutics. It is organized into four sections: “Preformulation”, “Formulation Design and Approaches”, “Characterization and Analysis”, and “Cocrystal Engineering”. The approaches discussed enhance the overall quality of treatment and overcome the side effects of available therapies. The book is a collection of scholarly literature relevant to pharmaceutical technology and existing pharmaceutical technologies. It is a useful reference for industrial personnel working on developing novel pharmaceutical dosage forms.
We like to imagine that medicine is based on evidence and the results of fair testing and clinical trials. In reality, those tests and trials are often profoundly flawed. We like to imagine that doctors who write prescriptions for everything from antidepressants to cancer drugs to heart medication are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators have some code of ethics and let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct in the medical industry affects us on a global scale. With Goldacre's characteristic flair and a forensic attention to detail, Bad Pharma reveals a shockingly broken system and calls for regulation. This is the pharmaceutical industry as it has never been seen before.
